A Phase IIb Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, Dose Ranging Study of Atuliflapon in Participants with Proteinuric CKD

Details

Language :

English

ISSN :

10466673 and 15333450

Volume :

34

Issue :

11, Number 11 Supplement 11

Database :

Supplemental Index

Journal :

Journal of the American Society of Nephrology

Publication Type :

Periodical

Accession number :

ejs66272205

Full Text :

https://doi.org/10.1681/ASN.20233411S1677c